An RT-PCR study of 5-HT6 and 5-HT7 receptor mRNAs in the hippocampal formation and prefrontal cortex in schizophrenia

Schizophrenia Research

Volumn 57, Issue 1, 2002, Pages 15-26

  East, S Z ^a   Burnet, P W J ^a   Kerwin, R W ^b   Harrison, P J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

5 Hydroxytryptamine (5 HT); Human brain; Neuroleptic; Psychosis; Serotonin 6; Serotonin 7

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; SEROTONIN 6 RECEPTOR; SEROTONIN 7 RECEPTOR;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG TARGETING; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; NEUROTRANSMISSION; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHIZOPHRENIA;

ANIMALS; ANTIPSYCHOTIC AGENTS; DISEASE MODELS, ANIMAL; DNA PRIMERS; HIPPOCAMPUS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SEROTONIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SCHIZOPHRENIA;

EID: 0036723286     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(01)00323-1     Document Type: Article

References (76)

1. Serotonin-glutamate interactions: A new target for antipsychotic drugs
2. 2A receptors and clozapine response
3. 7) positively linked to adenylate cyclase
4. 5,6,7 subunit immunoreactivity on apical pyramidal cell dendrites in hippocampus of schizophrenics and manic depressives
5. 6 receptor antagonist, Ro 04-6790, in rats
6. 3H]Ro 63-0563 labels 5-Hydroxytryptamine receptor binding sites in rat and porcine striatum
7. 6 receptor in the rat brain: A study using antisense oligonucleotides
8. 6 receptors as emerging targets for drug discovery
9. 2A receptor mRNAs in human hippocampus suing a reverse transcriptase-polymerase chain reaction (RPCR) technique and their correlations with age and binding site densities
10. 2A receptor mRNAs and binding site densities are differentially altered in schizophrenia
11. Perspectives on the role of serotonergic mechanisms in the pharmacology of schizophrenia
12. Interactions between monoamines, glutamate, and GABA in schizophrenia
13. 7 receptor levels in the rat brain
14. 7 receptors in the rat hypothalamus without alteration in exploratory behaviour or neuroendocrine function
15. Multiple microvascular and astroglial 5-hydroxytryptamine receptor subtypes in human brain: Molecular and pharmacologic characterization
16. 6 antagonist SE-271046 on striatal and frontal cortex extracellular concentrations of noradrenaline, dopamine, 5-HT, glutamate and aspartate
17. Decreased expression of mRNAs encoding non-NMDA glutamate receptors GluR1 and GluR2 in medial temporal lobe neurons in schizophrenia
18. GluR2 glutamate receptor subunit flip and flop isoforms are decreased in the hippocampal formation in schizophrenia: A reverse transcriptase-polymerase chain reaction (RT-PCR) study
19. Immunoautoradiographic evidence for a loss of α-amino-3-hydroxy-5-methyl-4-isoxazole propionate-preferring non-N-methyl-D-aspartate glutamate receptors within the medial temporal lobe in schizophrenia
20. Expression of complexin I and II mRNAs and their regulation by antipsychotic drugs in the rat forebrain
21. Synaptophysin gene expression in schizophrenia: An investigation of synaptic pathology in the cerebral cortex
22. Cerebellar synaptic protein expression in schizophrenia
23. 6 receptor mRNA levels in rat brain
24. 6 receptor mRNA in the central nervous system of control or 5, 7-dihydroxytryptamine-treated rats
25. 6 receptor-like material in the rat central nervous system
26. 6 serotonin receptors may reflect psychoactive profile
27. 7 receptor in rat brain
28. Complementary DNA for human T-cell cyclophilin
29. 2a receptors
30. The neuropathology of schizophrenia: A critical review of the data and their interpretation
31. 2A receptor and its gene in schizophrenia
32. Decreased hippocampal expression of a glutamate receptor gene in schizophrenia
33. The relative importance of premortem acidosis and postmortem interval for human brain gene expression studies: Selective mRNA vulnerability and comparison with their encoded proteins
34. Glutamate receptor expression in schizophrenic brain
35. 7) receptor isoforms in human and rat produced by alternative splicing: Species differences due to altered intron-exon organization
36. 7) receptor isoforms produced by alternative splicing
37. Abnormalities in 5-HT2A receptor mRNA expression in frontal cortex of chronic elderly schizophrenics with varying histories of neuroleptic treatment
38. 6 receptors in rat, pig and human brain tissue
39. 7(b)
40. Serotonin-dopamine interaction and its relevance to schizophrenia
41. Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem
42. 6 serotonin receptor
43. The molecular biology of serotonin receptors: Therapeutic implications for the interface of mood and psychosis
44. 1A (serotonin-1A) receptor mRNA expression in rat hippocampus after adrenalectomy
45. Catching up on schizophrenia: Natural history and neurobiology
46. Serotonergic basis of antipsychotic drug effects in schizophrenia
47. 7) implicated in the regulation of mammalian circadian rhythms
48. Gene expression profiles of laser-captured adjacent neuronal subtypes
49. The role of serotonin in antipsychotic drug action
50. Effects of the 5-HT6 receptor antagonist Ro 04-6790 on learning consolidation
51. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs
52. 7 receptors in rat brain by immunocytochemistry, in situ hybridization, and agonist stimulated cFos expression
53. 7 receptor pseudogene
54. 6 receptor variant produced by alternative splicing
55. 6 receptors in rat nucleus accumbens by antisense oligonucleotides
56. Distribution of kainate receptor subunit mRNAs in human hippocampus, neocortex and cerebellum, and bilateral reduction of hippocampal GluR6 and KA2 transcripts in schizophrenia
57. A human serotonin-7 receptor pseudogene
58. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors
59. 2C): Where structure meets function
60. A novel rat serotonin (5-HT6) receptor: Molecular cloning, localization and stimulation of cAMP accumulation
61. 7 serotonin receptor subtype
62. 6 receptor gene in schizophrenia
63. 6 receptors
64. 7 receptor: Cloning and pharmacologic characterisation of two receptor variants
65. 7 receptors
66. Association study of serotonin-6 receptor variant (C267T) with schizophrenia and aggressive behavior
67. 7 receptors: Current knowledge and future prospects
68. 6) receptor gene in bipolar affectiv disorder and schizophrenia
69. MRNAs for clozapine-sensitive receptors co-localize in rat prefrontal cortex neurons
70. Localization of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridization histochemistry
71. Reduced GAP-43 mRNA in dorsolateral prefrontal cortex of patients with schizophrenia
72. Association between schizophrenia and T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene
73. Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo
74. Serotonin-6 receptor variant (C267T) and clinical response to clozapine